Aktie A40AZD PHARMA-BIO SERV, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Pharma-Bio Serv, Inc.

Aktien

A40AZD

US71711N1000

PBSV

Markt geschlossen - OTC Markets
Andere Börsenplätze
 16:53:04 03.05.2024 		% 5 Tage % 1. Jan.
0,7499 USD +2,03 % Intraday Chart für Pharma-Bio Serv, Inc. +2,03 % -28,58 %
18.03. Pharma-Bio Serv, Inc. meldet Ergebnis für das erste Quartal bis zum 31. Januar 2024 CI
30.01. Pharma-Bio Serv, Inc. beschließt Sonderdividende, zahlbar am oder um den 15. Februar 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Pharma-Bio Serv, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024
Pharma-Bio Serv Announces Full Year Results
Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024
Pharma-Bio Serv, Inc. Reports Earnings Results for the Full Year Ended October 31, 2023
Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014.
Pharma-Bio Serv, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014.
Pharma-Bio Serv, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
PHARMA-BIO SERV, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
PHARMA-BIO SERV, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014.
PHARMA-BIO SERV, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Pharma-Bio Serv, Inc. Announces Special Dividend, Payable on or About April 14, 2023
PHARMA-BIO SERV, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
PHARMA-BIO SERV, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
PHARMA-BIO SERV, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014.
Pharma-Bio Serv, Inc. Reports Earnings Results for the Full Year Ended October 31, 2022
PHARMA-BIO SERV, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A40AZD Aktie
  4. Nachrichten Pharma-Bio Serv, Inc.
  5. Andere Sprachen